Wen-Chi Feng
- Co-authors
- Chih‐Hung HsuAnn‐Lii ChengKuen‐Feng ChenPei‐Jer ChenHui‐Ling ChenWei‐Tien TaiYu‐Yun ShaoYen‐Shen Lu
- Topics
- PI3K/AKT/mTOR signaling in cancer (5 papers)Cancer Mechanisms and Therapy (3 papers)Cell death mechanisms and regulation (2 papers)
- Partner nations
- TaiwanUnited States
In The Last Decade
Wen-Chi Feng
9 papers receiving 594 citations
Peers
Comparison fields: 5 of 70
- Molecular Biology 371
- Cancer Research 144
- Epidemiology 127
- Pathology and Forensic Medicine 124
- Oncology 115
Countries citing papers authored by Wen-Chi Feng
This map shows the geographic impact of Wen-Chi Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Chi Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Chi Feng more than expected).
Fields of papers citing papers by Wen-Chi Feng
This network shows the impact of papers produced by Wen-Chi Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Chi Feng. The network helps show where Wen-Chi Feng may publish in the future.
Co-authorship network of co-authors of Wen-Chi Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Chi Feng. A scholar is included among the top collaborators of Wen-Chi Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Chi Feng. Wen-Chi Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 45 | |
| 2 | 51 | |
| 3 | 1 | |
| 4 | 265 | |
| 5 | Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J Pharmacol Exp Ther 337: 155-161 | 18 |
| 6 | 68 | |
| 7 | 20 | |
| 8 | 1 | |
| 9 | 128 |
About Wen-Chi Feng
Wen-Chi Feng is a scholar working on Pathology and Forensic Medicine, Physiology and Molecular Biology, having authored 9 papers that have together received 597 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Mechanisms and Therapy (3 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Hepatology (110 citations), Cancer Research (144 citations) and Pathology and Forensic Medicine (124 citations). Wen-Chi Feng has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Chih‐Hung Hsu, Ann‐Lii Cheng, Kuen‐Feng Chen, Pei‐Jer Chen, Hui‐Ling Chen, Wei‐Tien Tai, Yu‐Yun Shao, Yen‐Shen Lu, Min‐Liang Kuo and Ching‐Shih Chen. Their work appears in journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.